Russell Investments Group’s Definium Therapeutics DFTX Stock Holding History

Russell Investments Group’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.22M	Buy	153,477 +34,013	+28%	+$840K	0.01%	1260
2026 Q1	$2.26M	Buy	119,464 +110,599	+1,248%	+$1.88M	﹤0.01%	1815
2025 Q4	$119K	Sell	8,865 -4,838	-35%	-$59.9K	﹤0.01%	3000
2025 Q3	$162K	Buy	13,703 +9,886	+259%	+$92.2K	﹤0.01%	2873
2025 Q2	$24.8K	Buy	3,817 +2,003	+110%	+$13.2K	﹤0.01%	3145
2025 Q1	$10.6K	Sell	1,814 -352	-16%	-$2.52K	﹤0.01%	3227
2024 Q4	$15.1K	Buy	2,166 +1,354	+167%	+$9.32K	﹤0.01%	3061
2024 Q3	$4.62K	Buy	+812	New	+$5.65K	﹤0.01%	3234

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Russell Investments Group's DFTX Position: Q2 2026 in Review

Russell Investments Group increased its Definium Therapeutics (DFTX) stake by 28% in Q2 2026, buying an estimated $840K and bringing the position to 153,477 shares worth $7.22M. The position accounts for 0.01% of the portfolio, ranked #1260.

Russell Investments Group first reported a position in DFTX in Q3 2024 and has held it in 8 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Russell Investments Group held 153,477 shares of Definium Therapeutics worth $7.22M as of Q2 2026.
Russell Investments Group bought 34,013 Definium Therapeutics shares in Q2 2026, an estimated $840K.
Definium Therapeutics made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #1260 holding.
Russell Investments Group first reported a position in Definium Therapeutics in Q3 2024 and has held it in 8 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.